- Home
- PRLD vs USEG Comparison
PRLD vs USEG Comparison
Compare PRLD & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- USEG
- Stock Information
- Founded
- PRLD 2016
- USEG 1966
- Country
- PRLD United States
- USEG United States
- Employees
- PRLD N/A
- USEG N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- USEG Oil & Gas Production
- Sector
- PRLD Health Care
- USEG Energy
- Exchange
- PRLD Nasdaq
- USEG Nasdaq
- Market Cap
- PRLD 50.1M
- USEG 42.2M
- IPO Year
- PRLD 2020
- USEG N/A
- Fundamental
- Price
- PRLD $0.88
- USEG $1.77
- Analyst Decision
- PRLD Strong Buy
- USEG Strong Buy
- Analyst Count
- PRLD 2
- USEG 2
- Target Price
- PRLD $4.50
- USEG $2.75
- AVG Volume (30 Days)
- PRLD 168.1K
- USEG 8.2M
- Earning Date
- PRLD 08-11-2025
- USEG 08-06-2025
- Dividend Yield
- PRLD N/A
- USEG N/A
- EPS Growth
- PRLD N/A
- USEG N/A
- EPS
- PRLD N/A
- USEG N/A
- Revenue
- PRLD $7,000,000.00
- USEG $16,340,000.00
- Revenue This Year
- PRLD N/A
- USEG $23.82
- Revenue Next Year
- PRLD N/A
- USEG N/A
- P/E Ratio
- PRLD N/A
- USEG N/A
- Revenue Growth
- PRLD N/A
- USEG N/A
- 52 Week Low
- PRLD $0.61
- USEG $0.81
- 52 Week High
- PRLD $6.80
- USEG $6.40
- Technical
- Relative Strength Index (RSI)
- PRLD 48.33
- USEG 57.29
- Support Level
- PRLD $0.85
- USEG $1.65
- Resistance Level
- PRLD $1.25
- USEG $2.43
- Average True Range (ATR)
- PRLD 0.10
- USEG 0.25
- MACD
- PRLD -0.02
- USEG 0.06
- Stochastic Oscillator
- PRLD 18.52
- USEG 35.78
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.